Ptc Therapeutics (PTCT) EBIT Margin Growth (1y) (2013 - 2026)
Ptc Therapeutics (PTCT) EBIT Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn | -6,600.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,600.00 |
| Dec 31, 2025 | 3,285.00 |
| Sep 30, 2025 | 2,913.00 |
| Mar 31, 2025 | 10,413.00 |
| Dec 31, 2024 | -7,807.00 |
| Sep 30, 2024 | 3,241.00 |
| Mar 31, 2024 | 3,174.00 |
| Dec 31, 2023 | 12,156.00 |
| Sep 30, 2023 | -2,871.00 |
| Jun 30, 2023 | -4,221.00 |
| Mar 31, 2023 | 480.00 |
| Dec 31, 2022 | -6,839.00 |
| Sep 30, 2022 | 3,568.00 |
| Jun 30, 2022 | 2,862.00 |
| Mar 31, 2022 | 2,505.00 |
| Dec 31, 2021 | 3,857.00 |
| Sep 30, 2021 | -2,052.00 |
| Jun 30, 2021 | 16,449.00 |
| Mar 31, 2021 | 5,302.00 |
| Dec 31, 2020 | -44.00 |